You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

antigen-specific immune cells in airways

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Antigen-specific T Cells in Antisynthetase Syndrome and

Not yet recruiting
  • Antisynthetase Syndrome
  • BAL antigen-specific Th1 cells and Th17 cells, ILC and MAIT
  • Dijon, France
  • +5 more
Aug 2, 2023

Psoriasis, Atopic Dermatitis Trial in Taipei (UVB treatment)

Recruiting
  • Psoriasis
  • Atopic Dermatitis
  • UVB treatment
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 24, 2022

Prostate Cancer Trial in New York (engineered autologous T cells, cyclophosphamide)

Active, not recruiting
  • Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 28, 2022

Glioblastoma Multiforme of Brain, Glioblastoma Multiforme Trial in Shenzhen (Antigen-specific IgT cells)

Enrolling by invitation
  • Glioblastoma Multiforme of Brain
  • Glioblastoma Multiforme
  • Antigen-specific IgT cells
  • Shenzhen, Guangdong, China
  • +1 more
Nov 23, 2021

B-Cell Acute Lymphoblastic Leukemia Trial in Shenzhen (Antigen-specific T cells CART/CTL and DCvac)

Recruiting
  • B-Cell Acute Lymphoblastic Leukemia
  • Antigen-specific T cells CART/CTL and DCvac
  • Shenzhen, Guangdong, China
    Shenzhen Geno-Immune Medical Institute
Mar 7, 2022

Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

Active, not recruiting
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • gene-modified T cells targeted
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2023

Melanoma Trial in New York (Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs))

Completed
  • Melanoma
  • Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 12, 2023

T-Cell Acute Lymphoblastic Leukemia Trial in Shenzhen (Antigen-specific T cells CAR-T/CTL and DCvac)

Recruiting
  • T-Cell Acute Lymphoblastic Leukemia
  • Antigen-specific T cells CAR-T/CTL and DCvac
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
Mar 14, 2022

Neuroblastoma Trial in Houston (GINAKIT Cells, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Neuroblastoma
  • GINAKIT Cells
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Jan 18, 2023

Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)

Recruiting
  • Liver Cell Carcinoma
  • +7 more
  • CATCH T cells
  • +2 more
  • Houston, Texas
    Houston Methodist Hospital
Dec 19, 2022

Sarcoma Trial in Houston (Autologous HER2-specific T cells, Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Sarcoma
  • Autologous HER2-specific T cells
  • +3 more
  • Houston, Texas
  • +1 more
Nov 21, 2022

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Ependymoma, Glioblastoma, Medulloblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR

Recruiting
  • Ependymoma
  • +3 more
  • IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
  • Duarte, California
    City of Hope Medical Center
Mar 9, 2022

Multiple Myeloma, Immune System Diseases Trial in Chapel Hill (CAR138 T Cells)

Recruiting
  • Multiple Myeloma
  • Immune System Diseases
  • CAR138 T Cells
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Jan 10, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
  • Houston, Texas
    M D Anderson Cancer Center
Jul 13, 2022

High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin

Not yet recruiting
  • High Grade B-Cell Non-Hodgkin's Lymphoma
  • +3 more
  • Anti-CD19-CAR CMV-specific T-lymphocytes
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2023

Acute Lymphoblastic Leukemia, Immune System Diseases, Immunoproliferative Disorders Trial in Chapel Hill (iC9-CAR19 cells,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • iC9-CAR19 cells
  • +3 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 21, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (MultiTAA-specific T cells)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • MultiTAA-specific T cells
  • Houston, Texas
  • +1 more
May 31, 2022

Platinum-Resistant Ovarian Carcinoma Trial in Duarte (Chimeric Antigen Receptor T-cells, Cyclophosphamide, Fludarabine)

Recruiting
  • Platinum-Resistant Ovarian Carcinoma
  • Chimeric Antigen Receptor T-cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jul 21, 2022

Malignant Melanoma Trial in Herlev (Cyclophosphamide, Fludarabine Phosphate, Multiple Antigen Specific Endogenously derived T

Recruiting
  • Malignant Melanoma
  • Herlev, Denmark
    National Center for Cancer Immune Therapy (CCIT-DK)
Sep 14, 2021

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib,

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Acalabrutinib
  • CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jun 16, 2022

Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Houston (HER2-specific T cells)

Recruiting
  • Brain Tumor, Recurrent
  • Brain Tumor, Refractory
  • HER2-specific T cells
  • Houston, Texas
  • +1 more
May 3, 2022

Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

Active, not recruiting
  • Acute Lymphocytic Leukemia
  • Lymphoma
  • Biological/Genetically Modified T cells
  • Cyclophosphamide-based chemotherapy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Glioblastoma Multiforme Trial in Chapel Hill (CAR.B7-H3T cells infusion)

Recruiting
  • Glioblastoma Multiforme
  • CAR.B7-H3T cells infusion
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 25, 2022

Hepatocellular Carcinoma Trial in Houston (GLYCAR T cells, Cytoxan, Fludarabine)

Active, not recruiting
  • Hepatocellular Carcinoma
  • GLYCAR T cells
  • +2 more
  • Houston, Texas
    Houston Methodist Hospital
Feb 13, 2022